مرور Volume 14, Issue 2 بر اساس عنوان

در حال نمایش موارد 1 - 5 از 5

  • Assessment of T helper 17-associated cytokines in third trimester of pregnancy 

    Poordast, Tahereh؛ Najib, Fateme Sadat؛ Baharlou, Rasoul؛ Bijani, Atena؛ Alamdarloo, Shaghayegh Moradi؛ Poordast, Alieh (Shiraz Institute for Cancer Research, 2017-06-01)
    Background: Preeclampsia is a common pregnancy-specific disorder associated with significant maternal and fetal morbidity and mortality worldwide. It has been proposed that the imbalance between two CD4+ ...

  • BALB/c Mice Immunity to Hydatidosis Induced by In-vitro Reared Echinococcus granulosus Adult Worm Antigens 

    Rahimi, Hamid Reza؛ Mohammadzadeh, Tahereh؛ Sadjjadi, Seyed Mahmoud؛ Sarkari, Bahador؛ Zahabiun, Farzaneh (Shiraz Institute for Cancer Research, 2017-06-01)
    Background: Echinococcosis is a zoonotic parasitic disease caused by the larval stage of Echinococcus granulosus. Several native and recombinant antigens, derived from different stages of E. ...

  • Immunodiagnostic Value of Echinococcus Granulosus Recombinant B8/1 Subunit of Antigen B 

    Savardashtaki, Amir؛ Sarkari, Bahador؛ Arianfar, Farzane؛ Mostafavi-Pour, Zohreh (Shiraz Institute for Cancer Research, 2017-06-01)
    Background: Cystic echinococcosis (CE), as a chronic parasitic disease, is a major health problem in many countries. The performance of the currently available serodiagnostic tests for the diagnosis of CE ...

  • Low 17β-estradiol Levels Are Better Inducers of Regulatory Conditioned T Cells In-Vitro 

    Fatemi, Ramina؛ Mirzadegan, Ebrahim؛ Vahedian, Zohreh؛ Zarnani, Amir Hassan؛ Jeddi-Tehrani, Mahmood؛ Idali, Farah (Shiraz Institute for Cancer Research, 2017-06-01)
    Background: 17β-estradiol (E2) has been known to modulate immune response. Recent studies indicate that E2 at pregnancy level plays a role in regulating T cell response. Objective: To ...

  • Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant 

    Borhani, Kiandokht؛ Bamdad, Taravat؛ Hashempour, Tayebeh (Shiraz Institute for Cancer Research, 2017-06-01)
    Background: Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers have shown that lenalidomide is ...